16332 Pooled long-term safety analysis of risankizumab in patients with moderate to severe psoriasis
Gordon K, Bachelez H, Blauvelt A, Strober B, Harbers S, Valdes J, Waterhouse B, Sinvhal R, Lebwohl M, Reich K. 16332 Pooled long-term safety analysis of risankizumab in patients with moderate to severe psoriasis. Journal Of The American Academy Of Dermatology 2020, 83: ab176. DOI: 10.1016/j.jaad.2020.06.793.Peer-Reviewed Original Research